These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11310939)

  • 1. Screening of plasma homocysteine in peripheral arterial disease.
    Loncar R; Hrboka V; Tabakovic-Loncar V; Ostojic Z; Deussen A
    Ann Med; 2001 Feb; 33(1):48-54. PubMed ID: 11310939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and peripheral arterial disease: systematic review and meta-analysis.
    Khandanpour N; Loke YK; Meyer FJ; Jennings B; Armon MP
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):316-22. PubMed ID: 19560951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
    Riba R; Nicolaou A; Troxler M; Homer-Vaniasinkam S; Naseem KM
    Atherosclerosis; 2004 Jul; 175(1):69-75. PubMed ID: 15186948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration.
    Bloemenkamp DG; Mali WP; Tanis BC; Rosendaal FR; van den Bosch MA; Kemmeren JM; Algra A; Visseren FL; van der Graaf Y
    Eur J Clin Invest; 2002 Aug; 32(8):549-55. PubMed ID: 12190953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of plasma homocysteine with peripheral arterial disease in the hypertensive adults: A cross-sectional study.
    Yu C; Ding C; Hu L; Shi Y; Zhao P; Liu JE; Zhang L; Sun D; Zhou W; Yu C; Wang T; Zhu L; Huang X; Bao H; Cheng X
    J Clin Hypertens (Greenwich); 2024 Mar; 26(3):286-294. PubMed ID: 38375979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease.
    Ozkan Y; Ozkan E; Simşek B
    Int J Cardiol; 2002 Mar; 82(3):269-77. PubMed ID: 11911915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease.
    Rassoul F; Richter V; Janke C; Purschwitz K; Klötzer B; Geisel J; Herrmann W
    Angiology; 2000 Mar; 51(3):189-96. PubMed ID: 10744006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
    Ridker PM; Stampfer MJ; Rifai N
    JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease.
    Liu M; Fan F; Liu B; Jia J; Jiang Y; Sun P; He D; Liu J; Li Y; Huo Y; Li J; Zhang Y
    Diabetes Metab Syndr Obes; 2020; 13():3383-3393. PubMed ID: 33061499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fifteen-year clinical prognosis and cardiovascular or limb event associated with homocysteine levels in peripheral arterial disease.
    Kumakura H; Funada R; Matsuo Y; Iwasaki T; Nakashima K; Tsuboi E; Ichikawa S
    J Cardiol; 2023 Nov; 82(5):423-428. PubMed ID: 37146875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia: marker of systemic atherosclerosis in peripheral arterial disease.
    Taute BM; Taute R; Heins S; Behrmann C; Podhaisky H
    Int Angiol; 2004 Mar; 23(1):35-40. PubMed ID: 15156128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some aspects of homocysteine metabolism in hemodialysis patients].
    Bednarek-Skublewska A; Buraczyńska M; Wawrzycki S; Baranowicz-Gaszczyk I; Ksiazek A
    Pol Arch Med Wewn; 2002 Nov; 108(5):1041-7. PubMed ID: 12685244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease.
    Mansoor MA; Bergmark C; Svardal AM; Lønning PE; Ueland PM
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):232-40. PubMed ID: 7749831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patients.
    Darius H; Pittrow D; Haberl R; Trampisch HJ; Schuster A; Lange S; Tepohl HG; Allenberg JR; Diehm C
    Eur J Clin Invest; 2003 Sep; 33(9):751-7. PubMed ID: 12925033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina.
    Guo H; Chi J; Xing Y; Wang P
    Indian J Med Res; 2009 Mar; 129(3):279-84. PubMed ID: 19491420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
    Bostom AG; Shemin D; Lapane KL; Nadeau MR; Sutherland P; Chan J; Rozen R; Yoburn D; Jacques PF; Selhub J; Rosenberg IH
    Atherosclerosis; 1996 Jun; 123(1-2):193-202. PubMed ID: 8782850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum homocysteine, fibrinogen, lipoprotein-a level, and peripheral arterial disease: a dose-response meta-analysis.
    Wang H; Wu P; Jiang D; Zhang H; Zhang J; Zong Y; Han Y
    Eur J Med Res; 2022 Nov; 27(1):261. PubMed ID: 36411481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease.
    Signorelli SS; Fatuzzo P; Rapisarda F; Neri S; Ferrante M; Oliveri Conti G; Fallico R; Di Pino L; Pennisi G; Celotta G; Anzaldi M
    Kidney Blood Press Res; 2006; 29(2):100-7. PubMed ID: 16809937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-surgical periodontal therapy on plasma homocysteine levels in Indian population with chronic periodontitis: a pilot study.
    Bhardwaj S; Prabhuji ML; Karthikeyan BV
    J Clin Periodontol; 2015 Mar; 42(3):221-7. PubMed ID: 25644517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.